Join CBSET’s partner CILcare at the digital BioFIT meeting, December 7-10, 2020. With more than 1,300 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event […]
Join CBSET at the DIGITAL RESI three-day virtual conference, November 17-19. The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI […]
Join CBSET at the MedTech Strategist Investment & Partnering Virtual Summit, November 17-19. Bringing together avast global medtech network, MedTech Strategist has structured a virtual event that will enable the global community to engage, network, and partner with the top players in the device industry. Please contact us to schedule an e-meeting around the MedTech […]
Join CBSET’s partner CILcare at the 3rd annual Neuropsychiatric Drug Development Summit November 10-12, 2020, 2020. Returning as an interactive, virtual meeting, this definitive industry meeting is focused on helping companies develop the next generation of more clinically effective therapeutics. With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a […]
Join CBSET’s partner CILcare at the 3rd annual Neuropsychiatric Drug Development Summit November 10-12, 2020, 2020. Returning as an interactive, virtual meeting, this definitive industry meeting is focused on helping companies develop the next generation of more clinically effective therapeutics. With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a […]
CBSET offers Scanning Electron Microscopy (SEM) services that complement our other services, including in-life studies, pathology services, and mechanical testing. We combine our advanced SEM techniques and experience in pathology and regulatory review to meet the critical needs of our clients, including assessment of tissue and material characterization after in vivo device treatments, investigation of device integrity […]
Abraham Tzafriri , Benny Muraj , Fernando Gacia-Polite , Antonio-Gabino Salazar-Martin , Peter Markham , Anna-Maria Spognardi , Brett Zani , Mazen Albaghdadi , Steve Alston , and Elazer Edelman. “Drug-Coated Balloon Contact Pressure Predicts Endoluminal Coating Distribution.” Background: Paclitaxel-coated balloons (PCBs) control iliofemoral atherosclerotic lesions, yet restenosis rates remain hight without calss effect. We […]
September 30, 2020—CBSET Inc., a not-for-profit translational research institute, announced the publication of a preclinical study, “Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients,” by Abraham R. Tzafriri, PhD, et al, online ahead of print in the Journal of Biomaterials.
“These preclinical studies transform our understanding of how drug coated balloons deliver drug to the artery and why there is no class effect, while also providing tools for understanding the role of tissue stiffening with disease. The combination of mechanistic insight with predictive modeling can help accelerate development of new technologies such as those including […]
LEXINGTON, MA — September 23, 2020 — CBSET Inc., a not-for-profit translational research institute, announced today that the company and its partner, CILcare, a leading CRO specializing in hearing disorders, have been nominated to receive a prestigious Prix Galien MedStartUp award for their collaboration in fighting hearing loss; the collaborators are nominated in the category […]